Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-23 / Exp. Hematol. 2017 Feb;46:48-55Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-14 / Bone Marrow Transplant. 2017 Feb;52(2):228-237Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers
/in Esophageal Carcinoma, Hyperthermia, International Publications, Uterine Cancer /von 2016-11-01 / Cell Rep 2016 11;17(6):1621-1631Novel vaccines for glioblastoma: clinical update and perspective
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-11-01 / Immunotherapy 2016 11;8(11):1293-1308
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution